The small GTPase Rac and its effectors, the Pak1 and p35/Cdk5 kinases, have been assigned important roles in regulating cytoskeletal dynamics in neurons. Our previous work revealed that the neuronal p35/Cdk5 kinase associates with Pak1 in a RacGTP-dependent manner, causing hyperphosphorylation and down-regulation of Pak1 kinase activity. We have now demonstrated direct phosphorylation of Pak1 on threonine 212 by the p35/ Cdk5 kinase. In neuronal growth cones, Pak1 phosphorylated on Thr-212 localized to actin and tubulin-rich areas, suggesting a role in regulating growth cone dynamics. The expression of a non-phosphorylatable Pak1 mutant (Pak1A212) induced dramatic neurite disorganization. We also observed a strong association between p35/Cdk5 and the Pak1 C-terminal kinase domain. Overall, our data show that in neurons, membrane-associated, active Pak1 is regulated by the p35/Cdk5 kinase both by association and phosphorylation, which is essential for the proper regulation of the cytoskeleton during neurite outgrowth and remodeling.
The small GTPase Rac and its effectors, the Pak1 and p35/Cdk5 kinases, have been assigned important roles in regulating cytoskeletal dynamics in neurons. Our previous work revealed that the neuronal p35/Cdk5 kinase associates with Pak1 in a RacGTP-dependent manner, causing hyperphosphorylation and down-regulation of Pak1 kinase activity. We have now demonstrated direct phosphorylation of Pak1 on threonine 212 by the p35/ Cdk5 kinase. In neuronal growth cones, Pak1 phosphorylated on Thr-212 localized to actin and tubulin-rich areas, suggesting a role in regulating growth cone dynamics. The expression of a non-phosphorylatable Pak1 mutant (Pak1A212) induced dramatic neurite disorganization. We also observed a strong association between p35/Cdk5 and the Pak1 C-terminal kinase domain. Overall, our data show that in neurons, membrane-associated, active Pak1 is regulated by the p35/Cdk5 kinase both by association and phosphorylation, which is essential for the proper regulation of the cytoskeleton during neurite outgrowth and remodeling.
The development of the mammalian central nervous system (CNS) 1 is determined by the correct migration of immature neurons and their ability to extend neurites and form synapses. In the cortex, proliferating neuronal precursors move while passing through different stages of the cell cycle. At set times, these precursors arrest and embark on a long distance migration to form distinct cortical layers where they pass through several stages of neurite remodeling, pathfinding, and synaptogenesis (1) . A fundamental role in all of these processes is played by the continuous restructuring of the neuronal cytoskeleton.
The p35/Cdk5 kinase is enriched in the developing CNS with the highest levels seen when neurons are migrating and remodeling (2) (3) (4) . It is a proline-directed serine/threonine kinase previously shown to promote neurite outgrowth and co-localize in axonal growth cones with F-actin (5) (6) (7) (8) (9) . Mice that lack Cdk5 or p35 exhibit a severely disrupted laminar structure of the cerebral cortex proposed to result from the inability of cortical neurons to migrate past each other (10 -14) . Axon guidance and fasciculation defects have also been observed in p35
Ϫ/Ϫ and Cdk5 Ϫ/Ϫ mice (12, 13) . Both p35 and Cdk5 are essential for the proper development of the Drosophila and Xenopus CNS in which alterations in kinase activity affect differentiation and the accuracy of axonal patterning (15, 16) . A role for the p35/ Cdk5 kinase has also been suggested in regulating synapses (17) (18) (19) (20) (21) , whereas deregulation of its activity may play a part in several neuropathologies, especially Alzheimer's (22, 23) .
The p35/Cdk5 kinase is a downstream effector of the small GTPase Rac1 (subsequently referred to as Rac) (24) . In fibroblasts, Rac was first shown to regulate the formation of lamellipodia (25) . In neurons, the function of Rac has been associated with dendritic remodeling, neurite branching, neurite outgrowth, synaptogenesis, and growth cone collapse (26 -28) . We have demonstrated a GTP-dependent association between p35 and Rac, making p35/Cdk5 the first known neuronal-specific Rac effector (24) . In Xenopus retinal ganglion cells, loss of p35/Cdk5 kinase activity can partially rescue defective axonogenesis induced by constitutively active Rac mutants, showing a conservation of this signaling pathway in vertebrates (29) . In transfected cell lines or primary neurons, the p35/Cdk5 kinase is found in association with Rac and the serine/threonine kinase Pak1, a well characterized Rac and Cdc42 effector (24) . Pak kinases are known to play an important role in regulating polarity, migration, and adhesion (30, 31) . In Drosophila retinal ganglion cells, axonal outgrowth and pathfinding is dependent on interactions between DPak and the adapter protein Dock, the kinase activity of DPak, and signals received from Trio, a Rac exchange factor (32, 33) . In mammals, Pak1 is highly enriched in the brain, specifically the cortex, at developmental stages when the p35/Cdk5 kinase is induced (34 -36) . In cultured rat cortical neurons, Pak1 co-localizes with p35 and Cdk5 at the distal tips of axonal growth cones, whereas overexpression of a membrane-targeted Pak1 in PC12 cells induces neurite outgrowth (24, 37) .
Our previous work revealed Pak1 phosphorylation and subsequent down-regulation of its kinase activity in the presence of p35/Cdk5 (24) . We have now observed that the p35/Cdk5 kinase associates with a large portion of the Pak1 kinase domain and directly phosphorylates Pak1 on a unique site. This phosphorylation is crucial for the proper regulation of the cytoskeleton during neurite outgrowth. Together our data reveal the complexity of p35/Cdk5-mediated regulation of Pak1 in differentiating neurons.
EXPERIMENTAL PROCEDURES

DNA Expression Vectors-Recombinant glutathione S-transferase
(GST)-fused Pak1 proteins for expression in Escherichia coli were a generous gift from Gary Bokoch (Scripps Research Institute). Wild type Pak1 with the C-terminal K-Ras farnesilation sequence was a kind gift from Jonathan Chernoff (Fox Chase Cancer Center). Fragments of Pak1 for expression in mammalian cells were generated by PCR using Pfu DNA polymerase (Stratagene) and subcloned into BamHI and ClaI sites of vector pEBG. Point mutations in wild type or Pak1R299 mu-tants were generated by PCR using the QuikChange TM Kit (Stratagene) following the manufacturer's protocol. Briefly, a pair of complementary primers 25-35 bases long was designed with the base pair changes located in the middle of the sequence. The DNA was amplified by PCR using Pfu-turbo polymerase, the parental strand was nicked by digestion with DpnI restriction endonuclease, and the mixture was transformed into competent BL21 E. coli (Stratagene).
Cell Culture and Transfection-COS7 and Swiss 3T3 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum at 37°C and 5% CO 2 . Transfections of COS7 cells were carried out using the calcium phosphate precipitation methods as described previously (24) . Swiss 3T3 fibroblasts were transfected using LipofectAMINE PLUS reagent following the manufacturer's protocol (Life Technologies, Inc.). Cortical and hippocampal neurons were obtained from embryonic stage (E) 17-19 rats. They were dissociated as described previously and cultured in Neurobasal media supplemented with factor B27, 2 mM L-glutamine, 0.06 mg/ml cysteine, and 1 mM sodium pyruvate (Life Technologies, Inc.) on poly-D-lysine and laminincoated culture dishes at 37°C and 5% CO 2 (24) . Transfections were carried out using a modified calcium phosphate precipitation method as described (5) .
Immunocytochemistry-The following antibodies were used for immunocytochemical detection at the indicated dilutions: ␤-galactosidase (1:1000, Promega), Pak1 (C-19, 1:300, Santa Cruz Biotechnology), tubulin (1:100, Sigma), and rhodamine-conjugated phalloidin (1:25 Sigma). Phosphospecific antibodies PK-16 and PK-18 were obtained by immunization of mice with the following peptide (KRSVIEPLPVT-(p)PTRDV), and the clones were selected on the basis of binding to the phosphorylated and not to the unphosphorylated form of this peptide (Sigma). The hybridoma supernatants were used at a 1:2 dilution and affinity-purified PK-18 at 1:250 dilution. Secondary antibodies were FITC-conjugated anti-mouse (1:150, Sigma) or Alexa 488-, Alexa 594-, and Alexa 633-conjugated anti-mouse or anti-rabbit (1:500 -1:1000, Molecular Probes). Primary neurons were fixed in 4% paraformaldehyde pre-warmed to 37°C as described previously (5) . Images of neuronal growth cones and Swiss 3T3 fibroblasts were collected using an Olympus fluoroview confocal microscope or Zeiss Axiovert and Openlab (Improvison) deconvoluting software, respectively.
Analysis of Neuronal Morphology-Neurons were examined using a Zeiss Axioscop microscope at ϫ25 magnification using a macro provided by Imaging Associates Ltd. Care was taken to examine isolated neurons to avoid false results. In all cases scoring was carried out exclusively within a radius of 100 m from the center of the soma. For each cell, the number of neurite crossover points was counted. The scoring was performed blind.
Preparation of GST Fusion Proteins-GST-fused proteins were isolated either from expressing E. coli or from transfected COS7 cells. In both cases cells were lysed in buffer A (25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, and 10% glycerol), and the lysates were incubated with glutathione-Sepharose beads for a minimum of 1 h at 4°C. The proteins were eluted using 20 mM glutathione and dialyzed against cold phosphate-buffered saline for a minimum of 3 h.
Western Blotting and Immunoprecipitations-The following antibodies were used in all applications: Pak1 (C-19; Santa Cruz Biotechnology), p35 (C-19; Santa Cruz Biotechnology), Cdk5 (DC-17), Myc-tag (9e10), T(PO 4 )P (TP-101, New England Biolabs), Pak1T212(PO 4 ) (PK18, P3232; Sigma), and GST (Santa Cruz Biotechnology). For Pak1/ p35/Cdk5 interactions, transiently transfected COS7 cells were lysed in STM-Nonidet P-40 buffer (10 mM Tris-HCl, pH 8, 0.25 M sucrose, 10 mM MgCl 2 , 0.5% Nonidet P-40, 1 mM dithiothreitol, protease, and phosphatase inhibitors). Then the lysates were incubated with glutathioneSepharose beads at 4°C, washed three times in buffer A, and resuspended in 1ϫ sample buffer. Transfected COS7 cells were lysed in buffer A containing protease and phosphatase inhibitors for all other experiments. Cytoplasmic and membrane fractionations were obtained as described previously using STM and STM-Nonidet P-40 buffer (24) . Dephosphorylation using potato acid phosphatase was carried out as described previously (24) .
Kinase Assays-Pak1 and p35/Cdk5 kinase assays were performed as described previously after standardization for Pak1 expression using a phosphorimaging device and ECL Plus immunodetection reagent (Amersham Biosciences, Inc.) (24) . When the 147-231 fragment was used, the GST tag was removed by thrombin cleavage as described previously (24) . For Pak1 in-gel kinase assays, immunoprecipitates were resolved on 10% polyacrylamide gels containing 0.5 mg/ml myelin basic protein (Sigma). The gels were denatured in 6 M guanidine hydrochloride followed by sequential renaturing in 50 mM Tris-HCl, pH 7.5, 5 mM ␤-mercaptoethanol, and 0.04% Tween 20. The kinase reaction was performed in 50 mM HEPES, pH 7.4, 10 mM MgCl 2 , 2 mM MnCl 2 , 2 mM dithiothreitol, 20 M ATP, and 10 Ci/ml [␥-32 P]ATP. p35/Cdk5 kinase assays were carried out as described previously (5) Two-dimensional Analysis-Two-dimensional tryptic-phosphopeptide mapping was performed on purified GST-Pak1 proteins phosphorylated in vitro or in vivo by the p35/Cdk5 kinase. Phosphorylated bands were transferred onto polyvinylidene difluoride membrane from which they were digested using L-1-tosylamido-2-phenylethyl chloromethyl ketone-treated trypsin. After several cycles of purification, the samples were standardized using Cerenkov counting and dotted onto microcrystalline cellulose TLC plates followed by electrophoresis in pH 1.9 buffer (using a Hunter thin-layer electrophoresis unit) and chromatography in phospho-chromatography buffer as described previously (24, 61) .
RESULTS
The p35/Cdk5 Kinase Phosphorylates Pak1-We have shown previously that Pak1 becomes phosphorylated when co-expressed with p35/Cdk5 in a RacGTP-dependent manner. Moreover, Pak1 is found in complex with p35/Cdk5 in wild type and not p35 Ϫ/Ϫ mouse cortices (24) . To confirm that Pak1 is indeed phosphorylated by p35/Cdk5, we co-expressed both kinases in COS7 cells in the presence of an active Rac mutant, RacL61. Using a phosphospecific antibody that recognizes a minimal Cdk consensus site, phosphorylated threonine adjacent to a proline (T(PO 4 )P), we were able to show extensive Pak1 phosphorylation only in the presence of the p35/Cdk5 kinase (Fig. 1A) . When a Cdk5 dominant negative mutant was used (Cdk5N144), Pak1 phosphorylation was reduced to basal levels, indicating the requirement for Cdk5 kinase activity.
Cdk5 is a member of the Cdk family of kinases shown to phosphorylate K(S/T)PX(K/R) motifs where X is preferably a basic amino acid while an acidic one is not tolerated well (38 -41) . Pak1 contains 10 (S/T)Ps, none of which fit the preferred Cdk5 consensus (Fig. 1B) . Six are present in the spacer region that separates the GTPase binding and kinase domains, three are present in the kinase domain, and one is present at the extreme C terminus of Pak1 that associates with G␤ proteins ( Fig. 1C) (42, 43) . We therefore carried out in vitro p35/ Cdk5 kinase assays using recombinant GST-fused Pak1 fragments as substrates. Fig. 1D shows phosphorylation of a kinase-dead Pak1 mutant (Pak1R299) by p35/Cdk5 that had been obtained by in vitro transcription and translation reactions. Interestingly, the region encompassing residues 147-231 was the best substrate and contains two putative targets, Thr-185 and Thr-212. Phosphorylation of 1-231 and 232-544 fragments was also observed. The 232-544 region contains the entire Pak1 kinase domain and was able to catalyze its own phosphorylation in the absence of the p35/Cdk5 kinase, consistent with the previously reported high levels of autophosphorylation (44 -46) . This was not observed for any other fragment of Pak1 ( Fig. 1E and data not shown). A Pak1 kinaseinactivating K299R mutation abolished any detectable phosphorylation of the 232-544 domain in the presence or absence of the p35/Cdk5 kinase, suggesting that the C terminus of Pak1 does not contain any p35/Cdk5 target sites. This was further confirmed by the inability of p35/Cdk5 to phosphorylate 232-442 and 443-544 fragments of Pak1 (Fig. 1E) .
Thr-212 Is a Direct Target of the p35/Cdk5 Kinase-The GST-Pak1R299 phosphorylated in vitro by the p35/Cdk5 kinase, followed by trypsin digestion, generates a single radioactive peptide when separated in two dimensions (24) . To determine whether the Pak1 (S/T)P sites contribute to this phosphorylation, we mutated five (Thr-185, Thr-212, Thr-427, Thr-481, and Thr-531) to alanines in the Pak1R299 back-ground to avoid additional Pak1 autophosphorylation. The mutant Pak1 proteins were expressed as GST fusions in COS7 cells, purified, and used in p35/Cdk5 in vitro kinase assays followed by digestion with trypsin and separation on thin layer chromatography (TLC) plates by electrophoresis and chromatography. Fig. 2A shows that only the Pak1A212R299 mutant was rendered unphosphorylatable in vitro.
To verify that Thr-212 phosphorylation is directly due to the activity of p35/Cdk5 and not another contaminating kinase, we performed a kinase assay using only recombinant proteins purified from E. coli. A truncated, active fragment of p35 (GSTp25) and GST-Cdk5 efficiently phosphorylated a fragment of Pak1 (147-231). This was prevented by a T212A mutation, indicating that Thr-212 is a direct target of the p35/Cdk5 kinase (Fig. 2B) .
In Vivo Pak1 Is Phosphorylated on Multiple Sites in a p35/ Cdk5-dependent and -independent Manner-To examine the regions of Pak1 that are targeted by the p35/Cdk5 kinase in vivo, we expressed GST-fused Pak1 fragments in COS7 cells in the presence or absence of p35, Cdk5, and RacL61. Pak1 was isolated from the transfectants and analyzed for the presence of phosphorylated TP residues by Western blotting using the anti-T(PO 4 )P antibody. The results revealed phosphorylation of only the N-terminal half of the protein, whereas the C terminus (residues 232-544) remained unphosphorylated (Fig. 3A) . The N-terminal phosphorylation mapped to the 147-231 region.
To further verify the results obtained in vitro, we compared the phosphorylation pattern of five mutants (T185A, T212A, T427A, T481A, and T531A) generated in the Pak1R299 background following expression in COS7 cells in the presence or absence of p35, Cdk5, and RacL61. Western blots revealed that only the GST-Pak1A212R299 mutant lacked any detectable phosphorylation (Fig. 3B ). This was confirmed using a MycPak1A212-expressing construct (data not shown). The results suggest that Thr-212 is also a major p35/Cdk5 target site in vivo, whereas Thr-185, Thr-427, Thr-481, and Thr-531 are not targeted by the kinase.
The GST-Pak1R299 phosphorylated in COS7 cells labeled with [ 32 P]orthophosphate resolves into several radioactive peptides upon digestion with trypsin and two-dimensional separation. One of the peptides co-migrates with the single in vitro labeled peptide, suggesting that the site(s) targeted in vitro is also an in vivo substrate(s) (24) . To confirm that Thr-212 is indeed the major amino acid in Pak1 phosphorylated by p35/ Cdk5 in vivo, we compared the patterns generated by the Pak1A212R299 mutant with two controls, Pak1R299 co-expressed with p35/Cdk5 or p35/Cdk5N144 and RacL61 in COS7 cells. Pak1R299 generated five distinct radioactive peptides, one of which (3) was absent from the T212A mutant (Fig. 3C) . The phosphorylation of peptide 3 was also highly reduced in the presence of the inactive p35/Cdk5N144 kinase. Peptide 3 comigrated with the single visible in vitro phosphorylated Pak1 fragment (data not shown), suggesting that Thr-212 is the major target of the p35/Cdk5 kinase both in vitro and in vivo. A schematic diagram of Pak1 shows previously mapped domains, the distribution of all (S/T)P sites, and how they are represented in the fragments for expression in E. coli (C). Bottom panels in panels D and E show Coomassie-stained gels. Asterisks mark the full-length GST-fused protein products. Peptides 1, 2, 4, and 5 were still evident in the Pak1A212R299 mutant, indicating that they were not due to Thr-212 phosphorylation. Interestingly, when Cdk5N144 was used, peptide 5 was also missing. These findings identify Thr-212 as the major p35/Cdk5 target site and the only phosphorylated amino acid on peptide 3. They also suggest that the p35/Cdk5 kinase may indirectly affect the phosphorylation of another site on Pak1 located on peptide 5.
Phosphorylation of Thr-212 Does Not Cause Pak1 Kinase Inhibition-Pak1 kinase activity is inhibited by p35/Cdk5 (24) . To determine whether this is due to phosphorylation of Thr-212, we examined the kinase activity of Pak1A212. COS7 cells were engineered to over-express wild type Pak1, Ala-212, or Glu-212 mutants alone in the presence of RacL61 or p35, Cdk5, and RacL61. Pak1 immunoprecipitates were subjected to an in-gel kinase assay using myelin basic protein as a substrate. The results revealed that Pak1A212 could be activated by RacL61 to a similar level as the wild type control. Furthermore, this mutant was inhibited by the p35/Cdk5 kinase, indistinguishably from the wild type control (Fig. 4A) . To confirm these findings, in vitro kinase assays were performed using histone H4 as a Pak1 substrate. The activation of Pak1A212 by RacGTP was again prevented by the presence of the p35/Cdk5 kinase (Fig. 4B) . These data suggested that the p35/Cdk5 kinase-mediated inhibition of Pak1 activity is not due singly to phosphorylation of Pak1 on Thr-212 and were confirmed by the Pak1E212 mutant, the kinase activity of which was indistinguishable from wild type Pak1 or Pak1A212 (Fig. 4A) . The GST-fused Pak1 fragments were examined for phospho-TP motifs using the anti-T(PO 4 )P antibody following expression in COS7 cells as shown (A). Note the increased phosphorylation of fulllength Pak1, the N-terminal half, and the 147-231 region upon coexpression with p35/Cdk5. The remaining areas on the N terminus and the entire C terminus were not phosphorylated. GST-fused Pak1 mutants generated in the Pak1R299 background were isolated from COS7 cells co-expressing as shown (B). Only Pak1R299A212 was devoid of phosphorylation. Lower panels in panels A and B are controls for expression levels of the individual proteins. ip, immunoprecipitates. C, top panel, 32 P incorporation into GST-Pak1R299 and GST-Pak1A212R299 when expressed in COS7 cells co-expressing as shown. Trypsin digestion of the radiolabeled Pak1R299 generated five detectable peptides. Peptide 3 was poorly phosphorylated in the presence of kinase-inactive Cdk5N144 and undetectable in the Pak1A212R299 mutant. Peptide 5 was unphosphorylated in the presence of Cdk5N144.
results also raised the possibility that inhibition of Pak1 is an indirect consequence of the p35/Cdk5 kinase.
The Pak1 Kinase Domain Interacts with p35/Cdk5-The Pak1 region surrounding Thr-212 lies close to its autoinhibition domain. This domain overlaps in part with the Rac/Cdc42 binding region and is able to interact with the C-terminal kinase domain (45) (46) (47) (48) . Because p35/Cdk5 can inhibit Pak1, we investigated the association domains of these two kinases. GST-Pak1 fragments were co-transfected with p35/Cdk5N144 and RacL61 in COS7 cells, and the glutathione pulldowns were examined for the presence of p35, Cdk5, and Rac. The dominant negative mutant of Cdk5 was used because it confers a more stable interaction with substrates partly by extending the half-life of p35 (49) . Full-length Pak1 associated with p35/ Cdk5N144 (Fig. 5A) (24) . Remarkably, a strong interaction was observed between the C-terminal half of Pak1 and p35/ Cdk5N144. Both halves of this domain (232-442 and 443-545) associated with p35/Cdk5N144 (Fig. 5A) . The ability of p35 to bind the Pak1 C terminus was unaltered in the absence of co-expressed Cdk5 (data not shown), indicating that the association was via p35 and confirming our previous observations (24) . The N-terminal truncated form of p35, p25, also bound the Pak1 C terminus (Fig. 5B) .
If inhibition of Pak1 is not dependent on its phosphorylation by p35/Cdk5 on Thr-212 but dependent on structural alterations caused by the association of these kinases, a kinaseinactive Cdk5 mutant should be as effective at Pak1 inhibition as its wild type counterpart. To test this, we compared Pak1 kinase activity after co-expression with p35/Cdk5 or p35/ Cdk5N144 and RacL61. Pak1 activity was down-regulated in the presence of p35/Cdk5N144, revealing that Cdk5 kinase activity is not required for Pak1 inhibition (Fig. 5C) .
Pak1 Is Phosphorylated on Thr-212 in Neurons-
The highest p35/Cdk5 activity is seen in the CNS during embryogenesis. We therefore examined whether neuronal Pak1 is phosphorylated by the p35/Cdk5 kinase in the developing mammalian CNS. Because the anti-T(PO 4 )P antibody clearly detects Pak1 phosphorylated at Thr-212, we used it to investigate Pak1 immunoprecipitates obtained from cultured rat embryo cortical neurons. Fig. 6A shows that indeed a proportion of immunoprecipitated Pak1 was phosphorylated at TP residues. The presence of Cdk5 in the Pak1 immunoprecipitates confirmed our previous findings that the kinases associate in neurons (24) .
To analyze the biological role of Pak1 phosphorylation on Thr-212, we developed a monoclonal antibody that only recognizes Thr-212-phosphorylated Pak1. Top two panels, strong association between p35/Cdk5N144 and the C-terminal portion of Pak1, which was retained by both proximal and distal regions of this domain. B, as in panel A, using the N-terminal truncated p35 protein, p25, which was also able to associate with the C-terminal domain of Pak1. C, kinase assay showing the ability of the inactive p35/Cdk5N144 complex to inhibit Pak1 activity in over-expressing COS7 cells indistinguishably from wild type p35/Cdk5. In panels A-C, the lower panels are controls for the expression levels and activity of individual proteins. ip, immunoprecipitates.
212 phosphospecific antibody (Fig. 6C) . Examination of lysates obtained from cultured primary cortical neurons revealed the presence of Thr-212-phosphorylated Pak1 in both membrane and cytoplasmic fractions (Fig. 6D) , whereas active Rac exclusively localized to neuronal membranes (Fig. 6E) .
In Growth Cones Pak1T212(PO 4 ) Localizes to F-actin and Tubulin-rich Areas-We examined Swiss 3T3 fibroblasts overexpressing wild type Pak1 or Pak1A212 in the presence of p35, Cdk5, and RacL61. No cells expressing Pak1A212 had increased staining with the phosphoT212 antibody as compared with the basal levels seen in non-transfected cells, showing the specificity of this reagent. In contrast, all the cells co-expressing wild type Pak1, p35/Cdk5, and RacL61 showed the clear presence of Thr-212-phosphorylated Pak1 (Fig. 7A) . These phosphorylated species were evident in the cytoplasm and membrane and co-localized with staining for total Pak1. The presence of both kinases and RacL61 severely disrupted the shape of the cells (Fig. 7A) .
Analysis of cultured cortical and hippocampal neurons revealed an enrichment of endogenous Thr-212-phosphorylated Pak1 in axonal and dendritic growth cones. The highest degree of co-localization was seen with F-actin in lamellipodia and filopodia. Co-localization with microtubules was seen in areas where they had extended further from the growth cone shaft (Fig. 7B ). This was confirmed by triple staining for Thr-212-phosphorylated Pak1, F-actin, and tubulin (Fig. 7C) . The staining for T212-phospho-Pak1 was always punctate, indicating small domains of enrichment. Comparison of Thr-212 phosphorylated and total Pak1 revealed that a subpopulation of this kinase was phosphorylated on Thr-212 in all regions of its localization. Together, these findings show that the phosphorylation of Pak1 by p35/Cdk5 occurs in the peripheries of actively restructuring growth cones.
The Inability to Phosphorylate Pak1 on Thr-212 Causes Severe Disruptions of Neuronal Morphology-To determine the biological relevance of Pak1 phosphorylation, we compared primary cortical neurons over-expressing wild type Pak1 and the Pak1A212 mutant. Because previous reports suggested that membrane-targeted Pak1 is most effective in inducing neurite outgrowth (37), we used Pak1 fused to the 17-amino acid Cterminal membrane targeting sequence of Ras (Pak1-Caax). In all cases the constructs were over-expressed with ␤-galactosidase at a 6:1 ratio to ensure that most neurons that immunostained with an anti-␤-galactosidase antibody also co-expressed the DNA of interest (5). We found that neurons overexpressing Pak1A212-Caax exhibited a high level of disorganization with neurites frequently taking complex pathways. These abnormalities were not observed in neurons expressing ␤-galactosidase alone (Fig. 8A) . Over-expression of wild type Pak1 or the Pak1E212 mutant, designed to mimic the presence of a phosphate group on Thr-212, partially disrupted neuronal morphology to a much lower extent than the Ala-212 mutant.
We evaluated the morphological defects by scoring the number of times the neurites of a single transfected cell crossed over each other within a set radius of 100 m from the center of the soma. Care was taken to only examine isolated neurons, ensuring that neurites from neighboring cells were not counted. In addition, co-staining with glial markers (glial fibrillary acidic protein and S-100) was routinely performed. More than 100 neurons were scored blind from three separate transfections, and the data were divided into two categories exhibiting the percentage of cells with 0 to 5 and 5 to the maximum number of crossovers. Most of the neurons over-expressing ␤-galactosidase alone had up to 5 crossovers (82%) with only 18% exhibiting a greater degree of neurite complexity. However, 64% of neurons over-expressing Pak1A212-Caax were more complex (Fig. 8B) come increasingly apparent. It is therefore not surprising that two Rac effectors, the neuronal-specific p35/Cdk5 and neuronal-enriched Pak1 kinase, have also been shown to be essential for the proper functioning of CNS neurons. Work using Drosophila, Xenopus, and mammalian systems has indicated that functional alterations in p35, Cdk5, Pak1, or Rac have many overlapping but also distinct features. Overall, the common biological consequences can be summed up as defects in neuronal migration and axon and dendrite remodeling (3, 4, 26 -28) . The complexity of these phenotypes has suggested that the function of the p35/Cdk5 kinase in vivo is not simply to promote neuronal migration and neurite outgrowth but to provide a signaling mechanism to tightly regulate the accuracy of these events. We propose that this is achieved, at least in part, by the p35/Cdk5 kinase acting downstream of Rac and regulating the membrane-associated functions of the Pak1 kinase. To date it has been shown that localization and activity of the Pak1 kinase can have profound and varying consequences in different experimental systems, probably reflecting the dynamic complexity of its in vivo regulation (37, 50 -53) . Our work is the first to demonstrate the functional consequences of Pak1 regulation at the membranes of differentiating mammalian CNS neurons.
The structural features of Pak1 allow for several levels of regulation. In unstimulated cells Pak1 resides in the cytoplasm in an autoinhibited conformation achieved by virtue of interactions between an N-terminal region (amino acids 75-132) with the C-terminal kinase domain. Association with RacGTP or Cdc42GTP at the CRIB/PBD domain, which partially overlaps with the autoinhibitory sequences, induces conformational changes in the Pak1 protein coupled with autophosphorylation, which results in its activation (45) (46) (47) (48) . How active Pak1 is subsequently down-regulated is largely unknown. The p35/ Cdk5 kinase associates with and phosphorylates Pak1 in a RacGTP-dependent manner, suggesting that p35 binds active Pak1. We therefore propose that in neurons, the p35/Cdk5 kinase modulates the function of Pak1 subsequent to its activation.
We have demonstrated that phosphorylation of Pak1 by the p35/Cdk5 kinase takes place in vitro and in vivo on Thr-212. In Swiss 3T3 fibroblasts, co-expression of p35/Cdk5, Pak1, and constitutively active Rac results in extensive Pak1 phosphorylation on Thr-212, which localizes to the membrane and cytoplasm of these cells. In addition, a population of endogenous Pak1 is phosphorylated on Thr-212 in mouse and rat cortical (1) . Upon receptor-mediated stimulation, Pak1 is recruited to the membrane via proteins such as Nck, where it associates with GTP-bound Rac (which is membrane-associated via C-terminal geranyl-geranylation) and a putative interactor (X) through the 220 PVTP 213 domain (2). Cdk5 is indirectly associated with the membrane via newly synthesized p35, which is myristoylated and also associates with RacGTP. The p35/Cdk5 kinase phosphorylates Pak1 on Thr-212, thus preventing association with the unknown protein X (3). In addition, p35/Cdk5 associates with Pak1 extensively over its C-terminal kinase domain and more weakly with the N terminus. We propose that this interaction, in combination with Pak1 phosphorylation, acts to regulate the downstream signaling on the neuronal cytoskeleton. Because p35/Cdk5 is short-lived, its effects on membrane-bound Pak1 are transient, bringing the signaling pathway back to stage 1. and hippocampal neurons. In growth cones, Thr-212-phosphorylated Pak1 appears to outline distally extending microtubule bundles and co-localizes with F-actin. P35/Cdk5 phosphorylation of Pak1 may therefore affect the cross-talk between microtubules and microfilaments during the forward movement and turning of neuronal growth cones. The defects we observed upon over-expression of a membrane-targeted non-phosphorylatable Pak1 mutant further support this hypothesis. The Pak1A212 mutant remains down-regulatable by p35/Cdk5, suggesting that phosphorylation of Pak1 is not sufficient for p35/Cdk5-induced inhibition. The Pak1A212 mutant also shows no detectable impairment for Pak1/Pak1 association. 2 The crystal structure of Pak1 domains revealed that Thr-212 resides in a flexible region for which a structure could not be predicted (48) . It is conserved in mouse, human, and rat orthologues. Two other closely related members of the Pak family of kinases, Pak2 and Pak3, do not have a p35/Cdk5 phosphorylation site at the position equivalent to Thr-212. Therefore, in neurons, phosphorylation of Pak1 on Thr-212 may regulate a specific signaling pathway, distinguishing it from other members of this family of kinases.
Phosphorylation of Pak1 by a Cdk and association of the two kinases is evolutionarily conserved. The Saccharomyces cerevisiae Cdc28/Cln1 and Cdc28/Cln2 kinases have been shown to extensively phosphorylate Ste20, a member of the Pak family, predominantly at the late G 1 and S phases of the cell cycle (54 -56) . The Cln2-dependent repression of the pheromone signaling pathway was shown to take place by affecting the function of Ste20 through direct interaction (54, 56) . Cdc28/Cln2 also acts to abolish binding between Ste20 and the G␤ protein Ste4. In mammalian cells, Cdc2 was found to phosphorylate Pak1 on Thr-212 during mitosis.
3 Cdk5, Cdk2, and Cdc2 are highly homologous and have a similar substrate specificity (38 -40) . However, in postmitotic neurons, Cdk2 and Cdc2 are absent and/or inhibited, whereas Cdk5 is highly active (34, 57) . It is therefore likely that Cdk5 is the sole kinase responsible for phosphorylating Pak1 on Thr-212 in differentiating neurons of the CNS.
Because Pak1A212 is inhibited by p35/Cdk5, the cytoskeletal defects we observed in neurons over-expressing this mutant are most likely not due to alterations in the activity of Pak1 at the membrane. Rather we speculate that phosphorylation of Thr-212 regulates an interaction between Pak1 and another cellular protein. Interestingly, Thr-212 is part of a putative SH3 binding PXXP domain. Mutation of this and another downstream PXXP site was shown to reduce the ability of activated Pak1 to disassemble focal adhesions and cause the collapse of cell peripheries (44) . It had no effect on the ability of Pak1 to associate with the PIX/Cool/p85 exchange factor, which binds a non-conventional PXXP motif in close proximity (44, 58, 59) . Likewise, we have not observed any differences in the ability of Pak1A212 or Glu-212 mutants to associate with PIX/ Cool/p85 or Nck. (60) in which association with the membrane-bound RacGTP or Cdc42GTP followed by sequential autophosphorylation activates the kinase. We propose that RacGTP-mediated Pak1 activation makes Pak1 a target of the p35/Cdk5 kinase. Phosphorylation of Pak1 on Thr-212 regulates an interaction between Pak1 and an as yet unidentified signaling molecule. In addition, association between p35/Cdk5 and the Pak1 C-terminal domain may alter the Pak1 structure to resemble its inhibited state. Because p35 is membrane-associated and shortlived, these events are highly localized and transient. This is particularly important in growth cones in which frequently opposing effects take place simultaneously in areas of close proximity. In conclusion we believe that a subpopulation of Pak1 is regulated by the p35/Cdk5 kinase in the developing CNS, thus providing a rapid and localized effect on the cytoskeleton of postmitotic neurons.
